Evaluation of Gadoterate in Patients With Renal Dysfunction

Trial Profile

Evaluation of Gadoterate in Patients With Renal Dysfunction

Phase of Trial: Phase IV

Latest Information Update: 27 Mar 2017

At a glance

  • Drugs Gadoterate-meglumine (Primary)
  • Indications Kidney disorders
  • Focus Diagnostic use
  • Most Recent Events

    • 21 Mar 2017 Planned End Date changed from 1 Feb 2018 to 1 Jul 2019.
    • 21 Mar 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Jul 2018.
    • 21 Mar 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top